Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Immediate third-party review sought by device industry in Kassebaum FDA reform bill.

This article was originally published in The Gray Sheet

Executive Summary

THIRD-PARTY DEVICE REVIEW OPTION IMMEDIATELY UPON ENACTMENT of FDA reform legislation is being sought by device industry lobbyists for inclusion in Sen. Nancy Kassebaum's (R-Kan.) upcoming bill. Instead of delaying for several years the requirement that FDA farm out premarket device reviews to outside groups -- as proposed in draft legislation released by Kassebaum the week of Oct. 30 ("The Gray Sheet" Nov. 6, p. 3)-- industry reps say use of third parties should be imposed immediately.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005021

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel